Search...
Hybio Pharmaceutical Co., Ltd. announced that it expects to receive CNY 968 million in funding
I'm PortAI, I can summarize articles.
Hybio Pharmaceutical Co., Ltd. announced a private placement of shares expected to raise up to CNY 968 million. The issuance will not exceed 30% of total share capital, with a minimum issue price of 80% of the average price over the previous 20 trading days. The transaction, approved by the company's 6th Directorate, requires further approvals from shareholders, the Shenzhen Stock Exchange, and the China Securities Regulatory Commission. Shares will be non-transferable for 6 months post-issuance.
Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments